Group structure
29 companies in 8 countries
Loadingโฆ
29 companies in 8 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1โ25 of 813
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALENDRONATE-1010 mg ยท Tablet | Alendronic acid | Canada | Authorised | |
| ALENDRONATE-4040 mg ยท Tablet | Alendronic acid | Canada | Authorised | |
| ALENDRONATE-55 mg ยท Tablet | Alendronic acid | Canada | Authorised | |
| ALENDRONATE-7070 mg ยท Tablet | Alendronic acid | Canada | Marketed | 2008 |
| ALLOPURINOL-100100 mg ยท Tablet | Allopurinol | Canada | Marketed | 1982 |
| ALLOPURINOL-200200 mg ยท Tablet | Allopurinol | Canada | Marketed | 1995 |
| ALLOPURINOL-300300 mg ยท Tablet | Allopurinol | Canada | Marketed | 1982 |
| ALMOTRIPTAN12.5 mg ยท Tablet | Almotriptan | Canada | Marketed | 2014 |
| AMLODIPINE10 mg ยท Tablet | Amlodipine | Canada | Marketed | 2009 |
| AMLODIPINE2.5 mg ยท Tablet | Amlodipine | Canada | Marketed | 2009 |
| AMLODIPINE5 mg ยท Tablet | Amlodipine | Canada | Marketed | 2009 |
| ARIPIPRAZOLE15 mg ยท Tablet | Aripiprazole | Canada | Marketed | 2019 |
| ARIPIPRAZOLE2 mg ยท Tablet | Aripiprazole | Canada | Marketed | 2019 |
| ARIPIPRAZOLE20 mg ยท Tablet | Aripiprazole | Canada | Marketed | 2019 |
| ARIPIPRAZOLE30 mg ยท Tablet | Aripiprazole | Canada | Marketed | 2019 |
| ARIPIPRAZOLE5 mg ยท Tablet | Aripiprazole | Canada | Marketed | 2019 |
| ARIPIPRAZOLE10 mg ยท Tablet | Aripiprazole | Canada | Marketed | 2019 |
| CANDESARTAN16 mg ยท Tablet | Candesartan cilexetil | Canada | Marketed | 2012 |
| CANDESARTAN32 mg ยท Tablet | Candesartan cilexetil | Canada | Marketed | 2014 |
| CANDESARTAN8 mg ยท Tablet | Candesartan cilexetil | Canada | Marketed | 2012 |
| CANDESARTAN-HCTZ16.0 mg + 12.5 mg ยท Tablet | Candesartan cilexetil, Hydrochlorothiazide | Canada | Marketed | 2012 |
| CARVEDILOL25.0 mg ยท Tablet | Carvedilol | Canada | Marketed | 2009 |
| CARVEDILOL3.125 mg ยท Tablet | Carvedilol | Canada | Marketed | 2009 |
| CARVEDILOL6.25 mg ยท Tablet | Carvedilol | Canada | Marketed | 2009 |
| CARVEDILOL12.5 mg ยท Tablet | Carvedilol | Canada | Marketed | 2009 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 804 | 351 | 453 | CompaniesAll medicines |
| Netherlands | 4 | 4 | 0 | CompaniesAll medicines |
| Spain | 3 | 2 | 1 | CompaniesAll medicines |
| Brazil | 1 | 0 | 1 | CompaniesAll medicines |
| Croatia | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Australia, Colombia, Italy, Malaysia, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Agรชncia Nacional de Vigilรขncia Sanitรกria (Anvisa), DATAVISA open-data register; source modification 2026-10-07, acquired 2026-10-07 UTC.
Licence: Brazil federal open-data reuse, Decreto 8777/2016, consolidated article 4 as amended by Decreto 9903/2019
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Czech Ministry of Finance, ARES; Ministry of Justice commercial register (VR), Czech Statistical Office (RES), exact IฤO, source record datumAktualizace and retrieval date. Structured extraction by Prognia.
Licence: Czech statutory open data; ARES reuse and operating terms
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Report an error or request removalCorrections from the company itself are welcome.
Keep PROโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callLicence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Oficiul Naศional al Registrului Comerศului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licence: Creative Commons Attribution
Lรคkemedelsverket, Sweden, Fรถrvaringstemperatur och hรฅllbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Lรคkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Well-known pharmaceutical groups, each with all its companies.